Engaging Individuals with Substance Use Disorders in Tobacco Treatment

The Harm Reduction Series is designed to provide caregivers and providers with information on best practices for caring for individuals who are actively using substances. The education series will teach ways to expand the treatment continuum to include engaging and keeping people safe when they are actively using substances including alcohol, opioids, stimulants, and tobacco. The series is designed for a broad range of audiences and each module will be presented with an expert from the community to provide insight regarding strategies for engagement and implementation.

This training will focus on harm reduction techniques for nicotine and tobacco use. Participants will be able to identify evidence-based strategies that may reduce nicotine/tobacco consumption. How to individualize treatment by learning how to modify FDA-approved medications will be discussed. How to identify barriers to smoking cessation among individuals with substance use disorder, from both clinician and patient standpoints will be discussed.

CE/CME credits pending approval.

Intended audience

The entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction.

Objectives

• Participants will understand the disparities in smoking prevalence and tobacco-related health disease among patients with substance use disorders (SUD). 
• Participants will describe several barriers to smoking cessation among individuals with SUD, particularly opioid use disorder, from both clinician and patient standpoints.
• Participants will understand how to individualize treatment by learning how to modify FDA-approved medications to facilitate smokers to quit. 

Sponsored by

Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Substance Addiction Services.